Gene Expression Global Market Report 2026

Gene expression is the process by which the information encoded in a gene is used to produce a functional product, such as a protein. Proteins assembled through gene expression play a key role in determining cellular functions.

The main products in the gene expression market include kits and reagents, DNA chips or microarrays, and others. Kits and reagents are testing tools used to detect specific substances in the field or laboratory. Key processes include sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation. Techniques used encompass RNA expression, promoter analysis, protein expression, and post-translational modification analysis. These products and techniques are applied across areas such as drug discovery and development, clinical diagnostics, biotechnology, microbiology, and more.

Tariffs have influenced the gene expression market by increasing costs of imported kits, reagents, DNA chips, and laboratory instruments used across research and diagnostic workflows. These cost pressures have impacted drug discovery, clinical diagnostics, and biotechnology applications, with Asia-Pacific and Europe being most affected due to their reliance on cross-border supply chains. Tariffs have also delayed procurement cycles for high-end PCR systems and microarrays. However, they have encouraged regional manufacturing, local sourcing of consumables, and investments in domestic reagent production, supporting long-term supply chain resilience.

The gene expression market research report is one of a series of new reports from The Business Research Company that provides gene expression market statistics, including gene expression industry global market size, regional shares, competitors with a gene expression market share, detailed gene expression market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. This gene expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene expression market size has grown rapidly in recent years. It will grow from $12.67 billion in 2025 to $14.16 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to growth in academic genomics research funding, increasing prevalence of chronic and genetic diseases, early adoption of microarray technologies, expansion of pharmaceutical R&D pipelines, rising use of PCR-based techniques.

The gene expression market size is expected to see rapid growth in the next few years. It will grow to $22.22 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to advancement in RNA sequencing technologies, increasing focus on precision medicine, growth in clinical diagnostics applications, integration of AI in gene expression data analysis, expanding biotechnology industry investments. Major trends in the forecast period include expansion of single-cell gene expression analysis, increasing use of spatial transcriptomics, growing demand for high-throughput PCR platforms, rising adoption of multi-omics integration, standardization of gene expression workflows.

The increasing prevalence of chronic diseases is expected to drive the growth of the gene expression market in the coming years. Chronic diseases are long-term medical conditions that persist for extended periods, typically three months or more. Gene expression analysis is employed in chronic diseases to uncover the molecular mechanisms underlying these conditions, identify potential biomarkers, and develop targeted therapies. For example, in June 2024, the National Health Service, a UK-based government agency, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023-a rise of 18% from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is expected to fuel the expansion of the gene expression market.

Leading companies in the gene expression market are focusing on developing innovative products, such as gene detection assays, to gain a competitive edge and boost revenue. A gene detection assay is a technique used to identify and quantify specific genetic molecules, providing insights into the activity and abundance of particular genes. For example, in January 2023, Bio-Techne Corporation, a U.S.-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by launching the RNAscope Plus smRNA-RNA detection assay. This assay enables the simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers within a single tissue section, offering single-cell and subcellular resolution. Designed for large-scale studies, the assay is compatible with the Leica Bond Rx platform and is also available as a manual assay for convenient use. These therapeutic nucleic acids can modulate the expression and function of specific target genes, supporting the development of personalized treatments for inherited or acquired diseases that are resistant to conventional therapies.

In January 2023, Qiagen NV, a Germany-based molecular testing solutions company, acquired Verogen for an undisclosed sum. Through this acquisition, Qiagen obtained full access to Verogen's GEDmatch database and GEDmatch PRO portal, along with exclusive distribution rights for a version of the MiSeq sequencer specifically designed for forensic applications. Verogen is a U.S.-based company specializing in DNA-based biometric human identification products.

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene expression market includes revenues earned by entities by providing services such as transcription, mRNA processing, non-coding RNA maturation, RNA export, translation, folding, translocation, and protein transport. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Expression Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gene expression market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene expression ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene expression market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Kits And Reagents; DNA Chip Or Microarray; Other Products
• 2) By Process: Sample Collection; Purification; cDNA Synthesis And Conversion; PCR Analysis; Data Analysis And Interpretation
• 3) By Technique: RNA Exp; Promoter Analysis; Protein Exp. And Posttranslational Modification Analysis
• 4) By Application: Drug Discovery And Development; Clinical Diagnostics; Biotechnology And Microbiology; Other Applications
• Subsegments:
• 1) By Kits And Reagents: RNA Isolation Kits; cDNA Synthesis Kits; qPCR Kits; Reverse Transcription Kits; Other Reagents
• 2) By DNA Chip Or Microarray: Expression Microarrays; Genotyping Microarrays; Comparative Genomic Hybridization Arrays
• 3) By Other Products: Software For Data Analysis; Lab Instruments; Consumables
• Companies Mentioned: Thermo Fisher Scientific Inc.; Qiagen NV; Illumina Inc.; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; GE Healthcare; F Hoffmann-La Roche Ltd; Oxford Gene Technology IP Limited; Promega Corporation; OriGene Technologies Inc.; Luminex Corporation; Takara Bio Inc.; Danaher Corporation; ELITechGroup; Biocartis Group NV; Integragen SA; Oxford Nanopore Technologies Limited; Phalanx Biotech Group; Roche Holding AG; Sengenics Corporation Pte Ltd.; GenXPro GmbH; Twist Bioscience Corporation; Zymo Research Corporation; Abcam plc.; Bio-Techne Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.